A network pharmacology approach to determine active compounds and action mechanisms of Ge-Gen-Qin-Lian decoction for treatment of type 2 diabetes

Evidence-based Complementary and Alternative Medicine

Volumn 2014, Issue , 2014, Pages

  Li, Huiying ^a   Zhao, Linhua ^b   Zhang, Bo ^a,c   Jiang, Yuyu ^d   Wang, Xu ^a   Guo, Yun ^b   Liu, Hongxing ^b   Li, Shao ^a   Tong, Xiaolin ^b  

^a TSINGHUA UNIVERSITY   (China)

^b INSTITUTE OF CHINESE MATERIA MEDICA   (China)

^c Tianjin International Joint Academy of Biotechnology and Medicine   (China)

^d JIANGNAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84893786240     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2014/495840     Document Type: Article

References (69)

1. International Federation of Diabetes,. IDF diabetes atlas, http://www.diabetesatlas.org/
2. Ashcroft F. M., Rorsman P., Diabetes mellitus and the β cell: the last ten years. Cell 2012 148 6 1160 1171 2-s2.0-84858383401 10.1016/j.cell.2012.02.010
3. Kahn B. B., Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance. Cell 1998 92 5 593 596 2-s2.0-0032489358 10.1016/S0092-8674(00)81125-3 (Pubitemid 28141507)
4. Hamman R. F., Genetic and environmental determinants of non-insulin-dependent diabetes mellitus (NIDDM). Diabetes/Metabolism Reviews 1992 8 4 287 338 2-s2.0-0026969347 (Pubitemid 23171181)
5. Bonnefond A., Froguel P., Vaxillaire M., The emerging genetics of type 2 diabetes. Trends in Molecular Medicine 2010 16 9 407 416 2-s2.0-77956266047 10.1016/j.molmed.2010.06.004
6. Prokopenko I., McCarthy M. I., Lindgren C. M., Type 2 diabetes: new genes, new understanding. Trends in Genetics 2008 24 12 613 621 2-s2.0-56349158387 10.1016/j.tig.2008.09.004
7. Richard A. J., Stephens J. M., Emerging roles of JAK-STAT signaling pathways in adipocytes. Trends in Endocrinology and Metabolism 2011 22 8 325 332 2-s2.0-79960913754 10.1016/j.tem.2011.03.007
8. Samuel V. T., Shulman G. I., Mechanisms for insulin resistance: common threads and missing links. Cell 2012 148 5 852 871 2-s2.0-84857861919 10.1016/j.cell.2012.02.017
9. Welters H. J., Kulkarni R. N., Wnt signaling: relevance to β -cell biology and diabetes. Trends in Endocrinology and Metabolism 2008 19 10 349 355 2-s2.0-55649098154 10.1016/j.tem.2008.08.004
10. Morral N., Novel targets and therapeutic strategies for type 2 diabetes. Trends in Endocrinology and Metabolism 2003 14 4 169 175 2-s2.0-0038408484 10.1016/S1043-2760(03)00031-6 (Pubitemid 36733902)
11. Larkins R. G., New concepts for treatment of non-insulin-dependent diabetes mellitus. Trends in Endocrinology and Metabolism 1997 8 5 187 191 2-s2.0-0030860790 10.1016/S1043-2760(97)00037-4 (Pubitemid 27343845)
12. Pujol A., Mosca R., Farrés J., Aloy P., Unveiling the role of network and systems biology in drug discovery. Trends in Pharmacological Sciences 2010 31 3 115 123 2-s2.0-77649182705 10.1016/j.tips.2009.11.006
13. Zhao L. H., Lian F. M., Ji H. Y., Zhou Q., Xia L., Tong X. L., Clinial examples of treatment for type 2 diabetes by professor Tong Xiao-lin using Ge-Gen-Qin-Lian decoction. Chinese Journal of Experimental Traditional Medical Formulae 2011 17 4 249 251
14. Zhao L. H., Ji H. Y., Ji B. W., Song J., Tong X. L., Exploration of Ge-Gen-Qin-Lian Decoction's effect on diabetes mellitus in theory. China Journal of Traditional Chinese Medicine and Pharmacy 2012 27 2 280 283
15. Zhang W., Liu C.-Q., Wang P.-W., Sun S.-Y., Su W.-J., Zhang H.-J., Li X.-J., Yang S.-Y., Puerarin improves insulin resistance and modulates adipokine expression in rats fed a high-fat diet. European Journal of Pharmacology 2010 649 1-3 398 402 2-s2.0-78049259598 10.1016/j.ejphar.2010.09.054
16. Hsu F.-L., Liu I.-M., Kuo D.-H., Chen W.-C., Su H.-C., Cheng J.-T., Antihyperglycemic effect of puerarin in streptozotocin-induced diabetic rats. Journal of Natural Products 2003 66 6 788 792 2-s2.0-0038204299 (Pubitemid 36782086)
17. Liu Y. M., Feng Q. J., Niu X., Song Q., Zhang X., Kang Y. M., Puerarin reduces blood sugar in the diabetic mice and improves hyperlipidemia in rats. The FASEB Journal 2006 20 A298
18. Li H.-T., Wu X.-D., Davey A. K., Wang J., Antihyperglycemic effects of baicalin on streptozotocin-nicotinamide induced diabetic rats. Phytotherapy Research 2011 25 2 189 194 2-s2.0-79551665811 10.1002/ptr.3238
19. Zhang H., Wei J., Xue R., Wu J.-D., Zhao W., Wang Z.-Z., Wang S.-K., Zhou Z.-X., Song D.-Q., Wang Y.-M., Pan H.-N., Kong W.-J., Jiang J.-D., Berberine lowers blood glucose in type 2 diabetes mellitus patients through increasing insulin receptor expression. Metabolism 2010 59 2 285 292 2-s2.0-74049139484 10.1016/j.metabol.2009.07.029
20. Weidner C., de Groot J. C., Prasad A., Freiwald A., Quedenau C., Kliem M., Witzke A., Kodelja V., Han C. T., Giegold S., Baumann M., Klebl B., Siems K., Müller-Kuhrt L., Schürmann A., Schüler R., Pfeiffer A. F., Schroeder F. C., Büssow K., Sauer S., Amorfrutins are potent antidiabetic dietary natural products. Proceedings of the National Academy of Sciences of the United States of America 2012 109 19 7257 7262 10.1073/pnas.1116971109
21. Tong X.-L., Zhao L.-H., Lian F.-M., Zhou Q., Xia L., Zhang J.-C., Chen X.-Y., Ji H.-Y., Clinical observations on the dose-effect relationship of Gegen Qin Lian Decoction on 54 out-patients with type 2 diabetes. Journal of Traditional Chinese Medicine 2011 31 1 56 59 2-s2.0-79956141290
22. Zhang C. H., Xu G. L., Liu Y. H., Rao Y., Yu R. Y., Zhang Z. W., Wang Y. S., Tao L., Anti-diabetic activities of Ge-Gen-Qin-Lian Decoction in high-fat diet combined with streptozotocin-induced diabetic rats and in 3T-L1 adipocytes. Phytomedicine 2013 20 3-4 3221 3229
23. Bai F., Xu Y., Chen J., Liu Q., Gu J., Wang X., Ma J., Li H., Onuchic J. N., Jiang H., Free energy landscape for the binding process of Huperzine A to acetylcholinesterase. Proceedings of the National Academy of Sciences of the United States of America 2013 110 11 4273 4278 10.1073/pnas.1301814110
24. Ohlson S., Designing transient binding drugs: a new concept for drug discovery. Drug Discovery Today 2008 13 9-10 433 439 2-s2.0-43049158125 10.1016/j.drudis.2008.02.001
25. Li S., Zhang B., Traditional Chinese medicine network pharmacology: theory, methodology and application. Chinese Journal of Natural Medicines 2013 11 2 110 120
26. Hopkins A. L., Network pharmacology: the next paradigm in drug discovery. Nature Chemical Biology 2008 4 11 682 690 2-s2.0-54249155522 10.1038/nchembio.118
27. Li S., Zhang Z. Q., Wu L. J., Zhang X. G., Li Y. D., Wang Y. Y., Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. IET Systems Biology 2007 1 1 51 60 2-s2.0-34249037449 10.1049/iet-syb:20060032 (Pubitemid 46779218)
28. Li S., Framework and practice of network-based studies for Chinese herbal formula. Journal of Chinese Integrative Medicine 2007 5 5 489 493 2-s2.0-34648827366 10.3736/jcim20070501 (Pubitemid 47455595)
29. Li S., Network systems underlying traditional Chinese medicine syndrome and herb formula. Current Bioinformatics 2009 4 3 188 196 2-s2.0-70549112019 10.2174/157489309789071129
30. Li S., Zhang B., Jiang D., Wei Y., Zhang N., Herb network construction and co-module analysis for uncovering the combination rule of traditional Chinese herbal formulae. BMC Bioinformatics 2010 11 supplement 11, article S6 2-s2.0-78650832745 10.1186/1471-2105-11-S11-S6
31. Li S., Network target: a starting point for traditional Chinese medicine network pharmacology. Zhongguo Zhongyao Zazhi 2011 36 15 2017 2020 2-s2.0-80053964470 10.4268/cjcmm20111502
32. Li S., Zhang B., Zhang N., Network target for screening synergistic drug combinations with application to traditional Chinese medicine. BMC Systems Biology 2011 5 supplement 1, article S10 2-s2.0-79959199033 10.1186/1752-0509-5- S1-S10
33. Stelzl U., Worm U., Lalowski M., Haenig C., Brembeck F. H., Goehler H., Stroedicke M., Zenkner M., Schoenherr A., Koeppen S., Timm J., Mintzlaff S., Abraham C., Bock N., Kietzmann S., Goedde A., Toksöz E., Droege A., Krobitsch S., Korn B., Birchmeier W., Lehrach H., Wanker E. E., A human protein-protein interaction network: a resource for annotating the proteome. Cell 2005 122 6 957 968 2-s2.0-25144498379 10.1016/j.cell.2005.08.029 (Pubitemid 41345212)
34. Jeong H., Mason S. P., Barabási A.-L., Oltvai Z. N., Lethality and centrality in protein networks. Nature 2001 411 6833 41 42 2-s2.0-0035799707 10.1038/35075138 (Pubitemid 32428180)
35. Hartwell L. H., Hopfield J. J., Leibler S., Murray A. W., From molecular to modular cell biology. Nature 1999 402 6761 C47 C52 2-s2.0-0033518234
36. Goldstein D. B., Common genetic variation and human traits. New England Journal of Medicine 2009 360 17 1696 1698 2-s2.0-65949107547 10.1056/NEJMp0806284
37. Schadt E. E., Molecular networks as sensors and drivers of common human diseases. Nature 2009 461 7261 218 223 2-s2.0-70249134919 10.1038/nature08454
38. Zhang B., Wang X., Li S., An integrative platform of TCM network pharmacology and its application on a Herbal Formula, Qing-Luo-Yin. Evidence-Based Complementary and Alternative Medicine 2013 2013 12 456747 10.1155/2013/456747
39. Wang Y., Xiao J., Suzek T. O., Zhang J., Wang J., Bryant S. H., PubChem: a public information system for analyzing bioactivities of small molecules. Nucleic Acids Research 2009 37 2 W623 W633 2-s2.0-67849104638 10.1093/nar/gkp456
40. Hamosh A., Scott A. F., Amberger J. S., Bocchini C. A., McKusick V. A., Online Mendelian Inheritance in Man (OMIM), a knowledgebase of human genes and genetic disorders. Nucleic Acids Research 2005 33 D514 D517 2-s2.0-13444266370 10.1093/nar/gki033 (Pubitemid 40207927)
41. Wishart D. S., Knox C., Guo A. C., Cheng D., Shrivastava S., Tzur D., Gautam B., Hassanali M., DrugBank: a knowledgebase for drugs, drug actions and drug targets. Nucleic Acids Research 2008 36 1 D901 D906 2-s2.0-38549151817 10.1093/nar/gkm958 (Pubitemid 351149842)
42. Zhao S., Li S., Network-based relating pharmacological and genomic spaces for drug target identification. PLoS ONE 2010 5 7 2-s2.0-77955628292 10.1371/journal.pone.0011764 e11764
43. Parsons A. B., Brost R. L., Ding H., Li Z., Zhang C., Sheikh B., Brown G. W., Kane P. M., Hughes T. R., Boone C., Integration of chemical-genetic and genetic interaction data links bioactive compounds to cellular target pathways. Nature Biotechnology 2004 22 1 62 69 2-s2.0-0347473810 10.1038/nbt919 (Pubitemid 38057958)
44. Huang D. W., Sherman B. T., Lempicki R. A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nature Protocols 2009 4 1 44 57 2-s2.0-61449172037 10.1038/nprot.2008.211
45. Li L. S., Zhang N. B., Li S., Ranking effects of candidate drugs on biological process by integrating network analysis and Gene Ontology. Chinese Science Bulletin 2010 55 26 2974 2980 2-s2.0-77957156174 10.1007/s11434-010- 4067-6
46. Kaiden Student A., Hsu R. Y., Lane M. D., Induction of fatty acid synthetase synthesis in differentiating 3T3-L1 preadipocytes. Journal of Biological Chemistry 1980 255 10 4745 4750 2-s2.0-0018869666 (Pubitemid 10060752)
47. Nelson B. A., Robinson K. A., Buse M. G., High glucose and glucosamine induce insulin resistance via different mechanisms in 3T3-L1 adipocytes. Diabetes 2000 49 6 981 991 2-s2.0-0034079122 (Pubitemid 30349421)
48. Kitano H., A robustness-based approach to systems-oriented drug design. Nature Reviews Drug Discovery 2007 6 3 202 210 2-s2.0-33847377573 10.1038/nrd2195 (Pubitemid 46344624)
49. Wagner A. B., SciFinder Scholar 2006: an empirical analysis of research topic query processing. Journal of Chemical Information and Modeling 2006 46 2 767 774 2-s2.0-33646241042 10.1021/ci050481b
50. Lee S.-J., Umano K., Shibamoto T., Lee K.-G., Identification of volatile components in basil (Ocimum basilicum L.) and thyme leaves (Thymus vulgaris L.) and their antioxidant properties. Food Chemistry 2005 91 1 131 137 2-s2.0-9644295898 10.1016/j.foodchem.2004.05.056 (Pubitemid 39572542)
51. Xu L. J., Lu F. E., Wei S. C., Use of berberine derivativein preparing medicament for treating type-2 diabetes, adjusting blood sugar and blood fat. Patents Number: CN100404534C, 2008
52. Yeh G. Y., Eisenberg D. M., Kaptchuk T. J., Phillips R. S., Systematic review of herbs and dietary supplements for glycemic control in diabetes. Diabetes Care 2003 26 4 1277 1294 2-s2.0-0042668497 10.2337/diacare.26.4.1277 (Pubitemid 36929285)
53. Zhen Z., Chang B., Li M., Lian F.-M., Chen L., Dong L., Wang J., Yu B., Liu W.-K., Li X.-Y., Qin P.-J., Zhang J.-H., Tong X.-L., Anti-diabetic effects of a coptis chinensis containing new traditional Chinese medicine formula in type 2 diabetic rats. American Journal of Chinese Medicine 2011 39 1 53 63 2-s2.0-78751551706 10.1142/S0192415X11008646
54. Li J. C., Shen X. F., Meng X. L., A traditional Chinese medicine JiuHuangLian (Rhizoma coptidis steamed with rice wine) reduces oxidative stress injury in type 2 diabetic rats. Food and Chemical Toxicology 2013 59 222 229 10.1016/j.fct.2013.06.005
55. Jiang X. F., Wang L. J., Li X. G., Zhao Z. Q., Zhu J. Y., Isolation of Jatrorrhizine and Epiberberine in Coptis chinensis and their in vitro Hypoglycemic Effect. Guizhou Agricultural Sciences 2011 39 9 44 46
56. Fu Y., Hu B. R., Tang Q., Effect of jatrorrhizine, berberine, Huanglian Decoction and compound-mimic prescription on blood glucose in mice. Chinese Traditional and Herbal Drugs 2005 36 4 548 551
57. Shirwaikar A., Rajendran K., Punitha I. S. R., Antidiabetic activity of alcoholic stem extract of Coscinium fenestratum in streptozotocin-nicotinamide induced type 2 diabetic rats. Journal of Ethnopharmacology 2005 97 2 369 374 2-s2.0-13544254451 10.1016/j.jep.2004.11.034 (Pubitemid 40222041)
58. Ali S., Igoli J., Clements C., Semaan D., Alamzeb M., Ur Rashid M., Shah S. Q., Ferro V. A., Gray A. I., Khan M. R., Antidiabetic and antimicrobial activities of fractions and compounds isolated from Berberis brevissima Jafri and Berberis parkeriana Schneid. Bangladesh Journal of Pharmacology 2013 8 3 336 342
59. Lee Y. S., Kim W. S., Kim K. H., Yoon M. J., Cho H. J., Shen Y., Ye J.-M., Lee C. H., Oh W. K., Kim C. T., Hohnen-Behrens C., Gosby A., Kraegen E. W., James D. E., Kim J. B., Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006 55 8 2256 2264 2-s2.0-33749336146 10.2337/db06-0006 (Pubitemid 44743622)
60. Diengott D., Mirsky I. A., Hypoglycemic action of indole-3-acetic acid by mouth in patients with diabetes mellitus. Proceedings of the Society for Experimental Biology and Medicine 1956 93 1 109 110 10.3181/00379727-93-22678
61. Hadimani M. B., Purohit M. K., Vanampally C., Van der Ploeg R., Arballo V., Morrow D., Frizzi K. E., Calcutt N. A., Fernyhough P., Kotra L. P., Guaifenesin derivatives promote neurite outgrowth and protect diabetic mice from neuropathy. Journal of Medicinal Chemistry 2013 56 12 5071 5078 10.1021/jm400401y
62. Su X., Pradaux-Caggiano F., Vicker N., Thomas M. P., Halem H., Culler M. D., Potter B. V. L., Adamantyl ethanone pyridyl derivatives: potent and selective inhibitors of human 11 β -hydroxysteroid dehydrogenase type 1. ChemMedChem 2011 6 9 1616 1629 2-s2.0-80052088740 10.1002/cmdc.201100182
63. Bartosz G., Food Oxidants and Antioxidants: Chemical, Biological, and Functional Properties 2013 CRC Press
64. Rahimi R., Nikfar S., Larijani B., Abdollahi M., A review on the role of antioxidants in the management of diabetes and its complications. Biomedicine and Pharmacotherapy 2005 59 7 365 373 2-s2.0-24044513942 10.1016/j.biopha.2005. 07.002 (Pubitemid 41219650)
65. Jovanovic L., Hassman D. R., Gooch B., Jain R., Greco S., Khutoryansky N., Hale P. M., Treatment of type 2 diabetes with a combination regimen of repaglinide plus pioglitazone. Diabetes Research and Clinical Practice 2004 63 2 127 134 2-s2.0-0347301652 10.1016/j.diabres.2003.09.004 (Pubitemid 38096358)
66. Li R., Ma T., Gu J., Liang X., Li S., Imbalanced network biomarkers for traditional Chinese medicine Syndrome in gastritis patients. Scientific Reports 2013 3, article 1543
67. Jiang B., Liang X., Chen Y., Ma T., Liu L., Li J., Jiang R., Chen T., Zhang X., Li S., Integrating next-generation sequencing and traditional tongue diagnosis to determine tongue coating microbiome. Scientific Reports 2012 2, article 936
68. Schofield C. J., Sutherland C., Disordered insulin secretion in the development of insulin resistance and Type 2 diabetes. Diabetic Medicine 2012 29 8 972 979 10.1111/j.1464-5491.2012.03655.x
69. Van Epps-Fung M., Williford J., Wells A., Hardy R. W., Fatty acid-induced insulin resistance in adipocytes. Endocrinology 1997 138 10 4338 4345 2-s2.0-0030886025 10.1210/en.138.10.4338 (Pubitemid 27408479)